Skip to main content

Table 1 Correlation between the expression of lncRNA OIP5-AS1 in multiple myeloma patients and clinicopathological characteristics

From: Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression

Clinicopathologic featurenExpression of lncRNA OIP5-AS1P Value
mean ± SD
Age (years)  0.2970
 ≥ 61200.65 ± 0.06 
 < 61180.62 ± 0.11 
Sex  0.6432
 Man180.63 ± 0.08 
 Woman200.64 ± 0.05 
Type of monoclonal immunoglobulin  0.5162
 IgG180.66 ± 0.06 
 IgA120.64 ± 0.05 
 IgD30.61 ± 0.12 
 Light chain only50.63 ± 0.04 
Peripheral blood cell count
 WBC, × 109/L  0.3214
  < 5.40190.58 ± 0.08 
  ≥ 5.40190.67 ± 0.11 
 Hb, g/L
  < 83.5190.62 ± 0.070.5879
  ≥ 83.5190.63 ± 0.03 
 PLT, × 109/L
  < 127190.64 ± 0.090.5213
  ≥ 127190.61 ± 0.06 
 ISS stage  < 0.001***
  I81.03 ± 0.08 
  II140.71 ± 0.04 
  III160.43 ± 0.09 
 IMWG risk stratification  < 0.001***
  Low risk71.2 ± 0.05 
  Intermediate risk190.68 ± 0.12 
  High risk120.59 ± 0.08 
  1. SD, standard deviation; WBC, white blood cell; Hb, hemoglobin; PLT, blood platelet; ISS, International Staging System; IMWG, International Myeloma Working Group. ***P < 0.001